The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $88.01

Today's change-1.36 -1.52%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
 

DexCom Inc

Nasdaq: DXCM
Last

(U.S.) $88.01

Today's change-1.36 -1.52%
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.

DexCom Inc down (U.S.)$1.36

DexCom Inc closed sharply lower Thursday, dropping (U.S.)$1.36 or 1.52% to (U.S.)$88.01. Shares have lost 6.11% over the last five days, but have gained 59.87% over the last year to date. This security has outperformed the S&P 500 by 104.43% during the last year.

Key company metrics

  • Open(U.S.) $89.89
  • Previous close(U.S.) $89.37
  • High(U.S.) $90.64
  • Low(U.S.) $87.82
  • Bid / Ask-- / --
  • YTD % change+59.87%
  • Volume716,904
  • Average volume (10-day)1,372,411
  • Average volume (1-month)1,219,905
  • Average volume (3-month)1,070,924
  • 52-week range(U.S.) $38.77 to (U.S.) $98.85
  • Beta0.46
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.26
Updated September 3 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.38%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue93738469
Total other revenue--------
Total revenue93738469
Gross profit66475947
Total cost of revenue27262522
Total operating expense97868374
Selling / general / administrative45393634
Research & development24202219
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income-4-132-5
Interest income (expense), net non-operating0000
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-131-5
Income after tax-4-131-5
Income tax, total----00
Net income-4-131-5
Total adjustments to net income--------
Net income before extra. items-4-131-5
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-131-5
Inc. avail. to common incl. extra. items-4-131-5
Diluted net income-4-131-5
Dilution adjustment----00
Diluted weighted average shares80787776
Diluted EPS excluding extraordinary itemsvalue per share-0.05-0.170.02-0.07
Dividends per sharevalue per share0.000.00--0.00
Diluted normalized EPSvalue per share-0.05-0.170.02-0.07